Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1450-1455

  Cirafici, Anna Maria ^a   Salvatore, Giuliana ^a   De Vita, Gabriella ^a   Carlomagno, Francesca ^a   Dathan, Nina A ^a   Visconti, Roberta ^a   Melillo, Rosa Marina ^a   Fusco, Alfredo ^b   Santoro, Massimo ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; METHIONINE; ONCOPROTEIN; PHENYLALANINE; SERINE; THREONINE; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; GENE CONTROL; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; ONCOGENE RET; POINT MUTATION; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA;

EID: 0030944153     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5073     Document Type: Article

References (28)

1. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H 1988 Cloning and expression of the ret protooncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3:571-578
2. Pachnis V, Mankoo B, Costantini F 1993 Expression of the c-RET proto-oncogene during mouse embryogenesis. Development 119:1005-1017
3. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox GM 1996 GDNF induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-a, a novel receptor for GDNF. Cell 85:1113-1124
4. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kaarlainen H, Martucciello G 1995 Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377-378
5. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fékété C, Ponder BAJ, Munnich A 1994 Mutations of the RET protooncogene in Hirschsprung's disease. Nature 367:378-380
6. Pasini B, Borrello MG, Greco A, Bongarzone I, Luo Y, Mondellini P, Alberti L, Miranda C, Arighi E, Bocciardi R, Seri M, Barone V, Radice MT, Romeo G, Pierotti M 1995 Loss of function effect of RET mutations causing Hirschsprung disease. Nature Genet 10:35-40
7. Carlomagno F, De Vita G, Berlingieri MT, de Franciscis V, Melillo RM, Colantuoni V, Kraus MH, Di Fiore PP, Fusco A, Santoro M 1996 Molecular heterogeneity of RET loss of function in Hirshsprung's disease. EMBO J 15:2717-2725
8. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
9. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA 1993 Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2:851-856
10. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JWM, van Amstel HCP, Romeo G, Lips CJM, Buys CHCM 1994 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376
11. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GFW, Jackson C, Tunnacliffe A, Ponder BAJ 1994 Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet 3:237-241
12. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA, Goodfellow P, Donis-Keller H 1994 Single missense mutation in the tyrosine-kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579-1583
13. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP 1995 Germ-line mutations of MEN2A and MEN2B activate RET as a dominant transforming gene by different molecular mechanisms. Science 267:381-383
14. Hanks SK 1991 Eukaryotic protein kinases. Curr Opin Struct Biol 1:369-383
15. Songyang Z, Carraway III KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ, Cantley LC 1995 Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-540
16. Iwashita T, Asai N, Murakami H, Matsuyama M, Takahashi M 1996 Identyrosine tification of tyrosine residues that are essential for transforming activity of the RET proto-oncogene with MEN2A or MEN2B mutation. Oncogene 12:481-487
17. Higuchi R 1990 Recombinant PCR. In: Innis MA, Gelfand DH, Sninski JJ, White TJ (eds) PCR Protocols: A Guide to Methods and Applications. Academic Press, Inc., San Diego, pp 177-183
18. Janssen-Timmen U, Lemaire P, Mattéi MG, Revelant O, Charnay P 1989 Structure, chromosome mapping and regulation of the mouse zinc-finger gene Krox-24; evidence for a common regulatory pathway for immediate-early serum-response genes. Gene 80:325-336
19. Califano D, Monaco C, De Vita G, Dathan NA, Possenti R, Fusco A, Santoro M, de Franciscis V 1995 Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC 12 cells. Oncogene 11:107-112
20. Califano D, D'Alessio A, Colucci-D'Amato GL, De Vita G, Monaco C, Santelli G, Di Fiore PP, Vecchio G, Fusco A, Santoro M, de Franciscis V 1996 A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. Proc Natl Acad Sci USA 93:7933-7937
21. Bairoch A 1992 PROSITE: a dictionary of sites and patterns in proteins. Nucleic Acids Res 20:2013-2018
22. Pinna LA 1990 Casein kinase 2: an eminence grise in cellular regulation? Biochem Biophys Acta 1054:267-284
23. Sargiacomo M, Scherer PE, Tang ZL, Casanova JE, Lisanti MP 1994 In vitro phosphorylation of caveolin-rich membrane domains: identification of an astyrosine sociated serine kinase activity as a casein kinase II-like enzyme. Oncogene 9:2589-2595
24. Perich JW, Meggio F, Kitas EA, Valerio RM, Johns RB, Pinna LA 1990 Phosphorylation of src-phosphopeptides by casein kinases-1 and-2:favourable effect of phosphotyrosine. Biochem Biophys Res Commun 170:635-642
25. Garnier J, Osguthorpe DJ, Robson B 1978 Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 120:97-120
26. Novotny J, Auffray C 1984 A program for prediction of protein secondary structure from nucleotide. sequence data: application to histocompatibility antigens. Nucleic Acids Res 12:243-255
27. Morgan DO, De Bondt HL 1994 Protein kinase regulation: insights from crystal structure analysis. Curr Opin Cell Biol 6:239-246
28. Hubbard SR, Wei L, Ellis L, Hendrickson WA 1994 Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372: 746-754